Overview
The Committee consists of 20 members, including the Chair, and also includes:
- Three nonvoting ex officio members representing the CDC, CMS, and FDA.
- Industry liaison, a nonvoting representative from AdvaMed.
- Designated Federal Officer.
The Designated Federal Officer (DFO) or their designee and the Executive Secretary are present at all meetings. They ensure that meetings are within applicable statutory, regulatory and Department of Health and Human Services General Administration manual directives.
Members
Learn more about Dr. Babady's current role and professional background.
Learn more about Mr. Black's current role and previous professional experience.
Learn more about Dr. Brown's current role and previous experience.
Learn more about Dr. Chapin's current role and professional background.
Learn more about Dr. Crawford's current role and previous professional experiences.
Learn more about Heather Duncan, her current role, and her previous experience.
Learn more about Dr. Edgerton's current role and professional background.
Learn more about Dr. Hagelstrom's current role and professional background.
Learn more about Dr. Heher's current role and previous professional experience.
Learn more about Dr. Koch's current role and professional background.
Learn more about Dr. Patel.
Learn more about Dr. Pentella.
Learn more about Dr. Luu's current role and previous professional experiences.
Learn more about Dr. Tuthill's current role and previous professional experience.
Learn more about Dr. Watkins' current role and professional background.
Ex Officio Members
Learn more about Mr. Brandush's current role and professional background.
Learn more about Dr. Fitzgerald's current role and previous experiences.
Learn more about Dr. Lias's current role and previous professional experience.
Content Source:
Division of Laboratory Systems (DLS)